CN103385963B - Chinese medicine preparation for treating angina pectoris caused by coronary heart disease - Google Patents
Chinese medicine preparation for treating angina pectoris caused by coronary heart disease Download PDFInfo
- Publication number
- CN103385963B CN103385963B CN201310312247.2A CN201310312247A CN103385963B CN 103385963 B CN103385963 B CN 103385963B CN 201310312247 A CN201310312247 A CN 201310312247A CN 103385963 B CN103385963 B CN 103385963B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to a medicine preparation, and particularly relates to a Chinese medicine preparation for treating angina pectoris caused by coronary heart disease. The Chinese medicine preparation comprises the following raw Chinese medicinal materials in parts by weight: 6-20 parts of radix puerariae, 6-12 parts of flos chrysanthemi, 3-10 parts of dried tangerine peel, 10-15 parts of semen cassiae, 10-15 parts of hawthorn, 6-15 parts of angelica sinensis, 10-15 parts of radix codonopsis, 8-12 parts of curnu cervi pantotrichum, 10-15 parts of manyprickle acanthopanax root, 6-15 parts of lotus seeds, 10-30 parts of poria cocos, 3-9 parts of ligusticum wallichii, 10-15 parts of radix astragali, 7-12 parts of fructus schizandrae, 10-15 parts of safflowers, and 10-15 parts of salviae miltiorrhizae. Proved by observing 98 cases, the total efficiency of patients with the confirmed angina pectoris caused by coronary heart disease is 90.8% after the Chinese medicine preparation is taken for one month.
Description
Technical field
The invention belongs to a kind of pharmaceutical product, particularly a kind of coronary heart disease for the treatment of causes anginal Chinese medicine preparation.
Background technology
Angina pectoris is a kind of by coronary insufficiency, and cardiac muscle sharply causes the clinical disease that the squeezing of paroxysmal shirtfront is felt or pain is feature with anoxia with temporary transient ischemia.The outbreak of primary disease many tired, exciting, catch cold, be satiated with food, during smoking.
The most frequently used method is to take nitroglycerine tablets.In addition medicine also has beta-Blocking agent as propranolol, and calcium ion antagonist is as nifedipine, diltiazem.At present, nitroglycerin has had membranous patch and oral spray.Membranous patch is used in left front chest outward, and drug percutaneous skin evenly absorbs, and continues the antianginal effect of performance in 24 hours.Oral spray is little because of consumption, absorbs sooner, and side effect is little and be subject to patient and welcome.These two kinds of dosage form prices are more expensive above, are unfavorable for promoting the use of.SUXIAO JIUXIN WAN is Chinese medicine preparation, during angina pectoris attacks, take in 10-15 grain number minute and take effect, this medicine also can long-term taking. and other are as medicine long-term takings such as storax pill for treating coronary heart disease, FUFANG DANSHEN PIAN, Xinnao Shutongs, can play the effect of the logical coronary circulation of relaxing, generally according to self-condition, select wherein 1,2 kind.Though it is various in style that angina pectoris therapeutic effect is satisfied with medicine, though long-acting single nitro isosorbide can maintain nearly 20 hours of effect, but clinical practice still has certain disadvantage, and external product is expensive, and patient can not bear because the side effect such as headache, flush are many sometimes.
Summary of the invention
The object of the invention is to provide a kind of coronary heart disease for the treatment of and causes anginal Chinese medicine preparation.
Specifically, treatment coronary heart disease causes anginal Chinese medicine preparation, and it is made by following weight portion raw material of Chinese medicine:
Radix Puerariae 6-20, Flos Chrysanthemi 6-12, Pericarpium Citri Reticulatae 3-10; Semen Cassiae 10-15, Fructus Crataegi 10-15, Radix Angelicae Sinensis 6-15, Radix Codonopsis 10-15, Cornu Cervi Pantotrichum 8-12, Radix Et Caulis Acanthopanacis Senticosi 10-15, Semen Nelumbinis 6-15, Poria 10-30, Rhizoma Chuanxiong 3-9, the Radix Astragali 10-15, Fructus Schisandrae Chinensis 7-12, Flos Carthami 10-15, Radix Salviae Miltiorrhizae 10-15.
Preferential treatment coronary heart disease of recommending causes anginal Chinese medicine preparation, and it is to be made by following weight portion raw material of Chinese medicine:
Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.
Described treatment coronary heart disease causes anginal Chinese medicine preparation, and it is to make pill or powder or capsule after all components is cleaned to mixing.
Each component effect of the present invention is as follows:
Radix Puerariae-expelling pathogenic factors from muscles for reducing heat, promoting the production of body fluid to quench thirst, treating measles, yang invigorating antidiarrheal;
Flos Chrysanthemi-dispelling wind and heat pathogens, suppressing the hyperactive liver improving eyesight;
Pericarpium Citri Reticulatae-drying dampness to eliminate phlegm, regulating qi-flowing for strengthening spleen;
Semen Cassiae-liver heat removing kidney tonifying, dispelling pathogenic wind for improving eyesight, blood pressure lowering relieving constipation;
Fructus Crataegi-promoting digestion and removing stagnation, antidiarrheal dysentery, dispelling the stagnated QI blood stasis dispelling, blood pressure lowering;
Radix Angelicae Sinensis-tonifying blood and regulating menstruation, promoting blood circulation and stopping pain, loosening bowel to relieve constipation;
Radix Codonopsis-invigorating the spleen and replenishing QI, nourishing blood to promote the production of body fluid;
Radix Ginseng-QI invigorating emergency treatment of collapse, benefit strengthening spleen and lung, promoting the production of body fluid to quench thirst, the mind calming and mentality promoting;
Cornu Cervi Pantotrichum-kidney-replenishing, benefiting essence-blood, bone and muscle strengthening;
Radix Et Caulis Acanthopanacis Senticosi-replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization;
Semen Nelumbinis-spleen reinforcing antidiarrheal, tranquilizing by nourishing the heart, supplementing the kidney to control the nocturnal;
Poria-promoting diuresis to eliminate damp pathogen, spleen invigorating invigorating middle warmer, mind tranquilizing and the heart calming;
Rhizoma Chuanxiong-blood-activating and qi-promoting, wind-expelling pain-stopping;
The Radix Astragali-tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, de-skin ulcer granulation promoting, inducing diuresis to remove edema;
Fructus Schisandrae Chinensis-astringing the lung, nourishing kidney, promote the production of body fluid, receive antiperspirant, arresting seminal emission;
Flos Carthami-invigorate blood circulation logical muscle, stasis-dispelling and pain-killing;
Radix Salviae Miltiorrhizae-blood circulation promoting and blood stasis dispelling, relieving restlessness are calmed the nerves, reducing swelling and alleviating pain.
Advantage of the present invention adopts natural material, has warming YANG activating QI, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving effect, and vascular plaque is had and reduces or disappear, and makes coronary artery unobstructed, thereby makes patients with coronary heart disease reach the therapeutic purposes of rehabilitation.Its compatibility is comprehensive simultaneously, and coronary heart disease is caused to angina pectoris treatment is rapid-action, and relatively Western medicine toxic and side effects is less.
The specific embodiment
Formula 1: Radix Puerariae 6, Flos Chrysanthemi 12, Pericarpium Citri Reticulatae 3; Semen Cassiae 15, Fructus Crataegi 10, Radix Angelicae Sinensis 15, Radix Codonopsis 10, Cornu Cervi Pantotrichum 12, Radix Et Caulis Acanthopanacis Senticosi 10, Semen Nelumbinis 15, Poria 10, Rhizoma Chuanxiong 9, the Radix Astragali 10, Fructus Schisandrae Chinensis 12, Flos Carthami 10, Radix Salviae Miltiorrhizae 15.
Formula 2: Radix Puerariae 20, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 10; Semen Cassiae 10, Fructus Crataegi 15, Radix Angelicae Sinensis 6, Radix Codonopsis 15, Cornu Cervi Pantotrichum 8, Radix Et Caulis Acanthopanacis Senticosi 15, Semen Nelumbinis 6, Poria 30, Rhizoma Chuanxiong 3, the Radix Astragali 15, Fructus Schisandrae Chinensis 7, Flos Carthami 15, Radix Salviae Miltiorrhizae 10.
Formula 3: Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.
Preparation method: mix after above-mentioned each prescription drug cleaning-drying, pulverize and to make pill or powder or capsule and all can.
Instructions of taking: every day three times, each 6-9 gram of former medicine.
Treatment by Chinese herbs angina pectoris clinical report of the present invention
From in January, 2013, observe altogether coronary heart disease in June, 2011 and cause angina pectoris 98 examples, observed result is as follows:
One, physical data
98 routine patients with coronary heart disease male 56, women 42 people, 49-78 years old ages, 79 routine complicated hypertension histories, the course of disease is mostly 4-9 years, 48 routine > 10 years.
Treating Stable Angina Pectoris of Coronary Artery Disease 61 examples, unstable angina 19 examples, angina pectoris 18 examples after heart infarction.Angina pectoris degree is sought unity of standard according to domestic Angina Pectoris from Coronary Artery Disease with Therapy of Combination of TCM with Western Medicine cooperative groups, slight 39 examples; Moderate 47 examples; Severe 12 examples.
Two, observational technique
Fill in unified observation table and observed by special messenger, stop any at least one week of angina pectoris medicine, 69 examples are observed cases need to contain nitroglycerin, 3 slices/day of < because of the state of an illness simultaneously.Nitroglycerin tongue needs the item records such as the every consumption per day of meter (sheet/day) treatment before measurement platelet white blood cell count, GPT, blood glucose, BUN, creatinine, routine urinalysis, cholesterol, triglyceride and high density lipoprotein, electrocardiogram containing exception.
Each oral the inventive method of all patients: every day three times, each 6-9 gram of former medicine.Preparation of the present invention is: Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.All components is in a gram weight.After each prescription drug cleaning-drying, mix, pulverizing is made powder and is taken.
Within one week, be a course for the treatment of, the above-mentioned item inspection of check after treatment, the unification of observation table is gathered to array data by special messenger makes brief summary.
Three, curative effect judging standard
Effective: " breathe hard, pained transference cure or obviously alleviate, other double disease and electrocardiogram are stable or progressive to some extent.
Invalid: all diseases and electrocardiogram are unchanged;
Four, result
1, therapeutic effect: effective 89 examples, no effect 9.It is 90.8% that the present invention treats angina pectoris clinical symptoms curative effect obvious effective rate;
2, adverse reactions of patients.In 98 examples, only 1 example has epigastric discomfort to feel sick, and loss of appetite untoward reaction, does not affect medication treatment, alleviates gradually disappearance in drug administration process, abnormal without other.
3, before and after all other treatments, lab testing has no significant change.
Claims (3)
1. treatment coronary heart disease causes anginal Chinese medicine preparation, it is characterized in that being made by following weight portion raw material of Chinese medicine:
Radix Puerariae 6-20, Flos Chrysanthemi 6-12, Pericarpium Citri Reticulatae 3-10; Semen Cassiae 10-15, Fructus Crataegi 10-15, Radix Angelicae Sinensis 6-15, Radix Codonopsis 10-15, Cornu Cervi Pantotrichum 8-12, Radix Et Caulis Acanthopanacis Senticosi 10-15, Semen Nelumbinis 6-15, Poria 10-30, Rhizoma Chuanxiong 3-9, the Radix Astragali 10-15, Fructus Schisandrae Chinensis 7-12, Flos Carthami 10-15, Radix Salviae Miltiorrhizae 10-15.
2. treatment coronary heart disease according to claim 1 causes anginal Chinese medicine preparation, it is characterized in that being made by following weight portion raw material of Chinese medicine:
Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.
3. treatment coronary heart disease according to claim 1 causes anginal Chinese medicine preparation, after it is characterized in that all components cleaning to mix, makes pill or powder or capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310312247.2A CN103385963B (en) | 2013-07-23 | 2013-07-23 | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310312247.2A CN103385963B (en) | 2013-07-23 | 2013-07-23 | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103385963A CN103385963A (en) | 2013-11-13 |
CN103385963B true CN103385963B (en) | 2014-08-13 |
Family
ID=49530498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310312247.2A Expired - Fee Related CN103385963B (en) | 2013-07-23 | 2013-07-23 | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103385963B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104645249B (en) * | 2015-03-17 | 2018-04-27 | 山东省立医院 | One kind treats treating coronary heart disease and angina pectoris |
CN105920296A (en) * | 2016-04-29 | 2016-09-07 | 王志敏 | Traditional Chinese medicine preparation for adjuvant treatment of angina pectoris in qi-and-yin-deficiency type coronary heart diseases, and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1437959A (en) * | 2002-02-10 | 2003-08-27 | 杨志东 | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method |
CN102145128A (en) * | 2011-03-30 | 2011-08-10 | 呼伦贝尔松鹿制药有限公司 | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
-
2013
- 2013-07-23 CN CN201310312247.2A patent/CN103385963B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1437959A (en) * | 2002-02-10 | 2003-08-27 | 杨志东 | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method |
CN102145128A (en) * | 2011-03-30 | 2011-08-10 | 呼伦贝尔松鹿制药有限公司 | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
冠心病的中药运用规律探讨;刘德泉;《光明中医》;19991231;第14卷(第04期);14-16 * |
刘德泉.冠心病的中药运用规律探讨.《光明中医》.1999,第14卷(第04期),14-16. |
Also Published As
Publication number | Publication date |
---|---|
CN103385963A (en) | 2013-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101843661B (en) | Chinese medicament for treating angina | |
CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
CN103385963B (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
CN101843712B (en) | Chinese medicament for treating angina | |
CN101843740B (en) | Chinese medicament for treating climacteric syndromes | |
CN101843660B (en) | Chinese medicament for treating tachycardia | |
CN101843753B (en) | Chinese medicament for treating angina | |
CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
CN101843717B (en) | Chinese medicament for treating coronary disease | |
CN101897935A (en) | Chinese medicinal composition for treating gastrolithiasis | |
CN102716434B (en) | Medicine for oral use for treating hypotension | |
CN101843835B (en) | Chinese medicament for treating coronary diseases | |
CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
CN101850034B (en) | Chinese medicament for treating angina | |
CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
CN101612233A (en) | A kind of Chinese medicine preparation of reducing swelling and alleviating pain | |
CN101850017A (en) | Chinese medicament for treating asthma | |
CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101843698A (en) | Chinese medicament for treating cervical spondylosis | |
CN101850055A (en) | Chinese medicament for treating coronary heart diseases | |
CN101850033A (en) | Chinese medicament for treating arteriosclerosis | |
CN101843792A (en) | Chinese medicament for treating angina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140813 Termination date: 20150723 |
|
EXPY | Termination of patent right or utility model |